Download presentation
Presentation is loading. Please wait.
Published byIwan Oesman Modified over 5 years ago
1
Impact of a targeted isolation strategy at intensive-care-unit-admission on intensive- care-unit-acquired infection related to multidrug-resistant bacteria: a prospective uncontrolled before–after study G. Ledoux, S. Six, R. Lawson, J. Labreuche, C. Blazejewski, F. Wallet, A. Duhamel, S. Nseir Clinical Microbiology and Infection Volume 22, Issue 10, Pages 888.e e18 (October 2016) DOI: /j.cmi Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions
2
Fig. 1 Study flowchart. ICU, intensive-care unit; LOS.
Clinical Microbiology and Infection , 888.e e18DOI: ( /j.cmi ) Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions
3
Fig. 2 Percentage of study patients with intensive-care-unit-acquired infection related to multidrug-resistant bacteria during each quarter of study periods. SIS, systematic isolation strategy; TIS, targeted isolation strategy; Q, quarter. Clinical Microbiology and Infection , 888.e e18DOI: ( /j.cmi ) Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions
4
Fig. 3 Percentage of patients with ICU-acquired infection related to multidrug resistant bacteria during the two study periods. p 0.316, 0.097, 0.015, 0.212, for methicillin-resistant Staphylococcus aureus (MRSA), ceftazidime or imipenem-resistant P. aeruginosa, extended spectrum beta-lactamase (ESBL)-producing Gram negative bacilli, A. baumannii, and S. maltophilia, respectively. Clinical Microbiology and Infection , 888.e e18DOI: ( /j.cmi ) Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions
5
Fig. 4 Percentage of patients with intensive-care-unit-acquired colonization related to multidrug resistant bacteria during the two study periods. p 0.99, 0.053, 0.034, 0.002, for methicillin-resistant Staphylococcus aureus (MRSA), ceftazidime or imipenem-resistant P. aeruginosa, extended spectrum beta-lactamase (ESBL)-producing Gram negative bacilli, A. baumannii, and S. maltophilia; respectively. Clinical Microbiology and Infection , 888.e e18DOI: ( /j.cmi ) Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.